Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Ontario, Canada.
Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Value Health. 2021 Apr;24(4):592-601. doi: 10.1016/j.jval.2020.10.005. Epub 2020 Nov 18.
Current guidelines mandate organ donation to be financially neutral such that it neither rewards nor exploits donors. This systematic review was conducted to assess the magnitude and type of costs incurred by adult living kidney donors and to identify those at risk of financial hardship.
We searched English-language journal articles and working papers assessing direct and indirect costs incurred by donors on PubMed, MEDLINE, Scopus, the National Institute for Health Research Economic Evaluation Database, Research Papers in Economics, and EconLit in 2005 and thereafter. Estimates of total costs, types of costs, and characteristics of donors who incurred the financial burden were extracted.
Sixteen studies were identified involving 6158 donors. Average donor-borne costs ranged from US$900 to US$19 900 (2019 values) over the period from predonation evaluation to the end of the first postoperative year. Less than half of donors sought financial assistance and 80% had financial loss. Out-of-pocket payments for travel and health services were the most reported items where lost income accounted for the largest proportion (23.2%-83.7%) of total costs. New indirect cost items were identified to be insurance difficulty, exercise impairment, and caregiver income loss. Donors from lower-income households and those who traveled long distances reported the greatest financial hardship.
Most kidney donors are undercompensated. Our findings highlight gaps in donor compensation for predonation evaluation, long-distance donations, and lifetime insurance protection. Additional studies outside of North America are needed to gain a global prospective on how to provide for financial neutrality for kidney donors.
目前的指南要求器官捐献在经济上保持中立,既不奖励也不剥削捐献者。本系统评价旨在评估成人活体肾脏捐献者所产生的直接和间接费用的规模和类型,并确定那些有经济困难风险的人。
我们在 2005 年及以后在 PubMed、MEDLINE、Scopus、国家卫生研究院经济评估数据库、经济学研究论文和 EconLit 上搜索了评估供者直接和间接费用的英文期刊文章和工作文件。提取了总费用、费用类型以及承担经济负担的供者特征的估计值。
确定了 16 项研究,涉及 6158 名供者。在从预捐评估到第一个术后年结束的期间内,平均供者承担的费用从 900 美元到 19900 美元(2019 年的价值)不等。不到一半的供者寻求经济援助,80%的供者有经济损失。旅行和医疗服务的自付费用是报告最多的项目,其中失去收入占总费用的比例最大(23.2%-83.7%)。确定了新的间接费用项目,包括保险困难、运动障碍和照顾者收入损失。来自低收入家庭和长途旅行的供者报告了最大的经济困难。
大多数肾脏供者的补偿不足。我们的研究结果突出了供者在预捐评估、长途捐赠和终身保险保护方面补偿不足的问题。需要在北美以外的更多研究来获得关于如何为肾脏供者提供经济中立的全球视角。